These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 24417911)

  • 1. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular adnexal follicular lymphoma: a multicenter international study.
    Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
    JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
    Aronow ME; Portell CA; Rybicki LA; Sweetenham JW; Singh AD
    Ophthalmology; 2013 Sep; 120(9):1915-9. PubMed ID: 23664470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
    Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
    Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
    Hashimoto N; Sasaki R; Nishimura H; Yoshida K; Miyawaki D; Nakayama M; Uehara K; Okamoto Y; Ejima Y; Azumi A; Matsui T; Sugimura K
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1509-14. PubMed ID: 21664061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
    Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma.
    Han JJ; Kim TM; Jeon YK; Kim MK; Khwarg SI; Kim CW; Kim IH; Heo DS
    Ann Hematol; 2015 Apr; 94(4):575-81. PubMed ID: 25338969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
    Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
    Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical features and outcomes in 21 patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma].
    Ning F; Ye J; Wei LQ; Li X; Wang JW
    Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):784-7. PubMed ID: 23290977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.
    Paik JS; Cho WK; Lee SE; Choi BO; Jung SE; Park GS; Kim SH; Yang SW; Cho SG
    Ann Hematol; 2012 Sep; 91(9):1393-401. PubMed ID: 22543827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
    Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
    JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
    Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
    Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
    Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
    Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extranodal marginal zone lymphoma in the ocular region: clinical, immunophenotypical, and cytogenetical characteristics.
    Sjö LD; Heegaard S; Prause JU; Petersen BL; Pedersen S; Ralfkiaer E
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):516-22. PubMed ID: 18775860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ; Ali S
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis and management of ocular lymphoma.
    Vollmer L
    Optom Vis Sci; 2013 Feb; 90(2):e56-62. PubMed ID: 23334313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
    Lee SE; Paik JS; Cho WK; Choi BO; Lee SN; Jung SE; Park KS; Kang CS; Kim SH; Yang SW; Cho SG
    Am J Hematol; 2011 Mar; 86(3):262-6. PubMed ID: 21328439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).
    Jackson AE; Mian M; Kalpadakis C; Pangalis GA; Stathis A; Porro E; Conconi A; Cortelazzo S; Gaidano G; Lopez Guillermo A; Johnson PW; Martelli M; Martinelli G; Thieblemont C; McPhail ED; Copie-Bergman C; Pileri SA; Jack A; Campo E; Mazzucchelli L; Ristow K; Habermann TM; Cavalli F; Nowakowski GS; Zucca E
    Oncologist; 2015 Oct; 20(10):1149-53. PubMed ID: 26268740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.